Search Page

1

Cite

Share

The metastatic niche: adapting the foreign soil.

Psaila B, Lyden D. Psaila B, et al. Nat Rev Cancer. 2009 Apr;9(4):285-93. doi: 10.1038/nrc2621. Nat Rev Cancer. 2009. PMID: 19308068 Free PMC article. Review.

Cite

Share

2

Cite

Share

Pre-metastatic niches: organ-specific homes for metastases.

Peinado H, Zhang H, Matei IR, Costa-Silva B, Hoshino A, Rodrigues G, Psaila B, Kaplan RN, Bromberg JF, Kang Y, Bissell MJ, Cox TR, Giaccia AJ, Erler JT, Hiratsuka S, Ghajar CM, Lyden D. Peinado H, et al. Among authors: psaila b. Nat Rev Cancer. 2017 May;17(5):302-317. doi: 10.1038/nrc.2017.6. Epub 2017 Mar 17. Nat Rev Cancer. 2017. PMID: 28303905 Review.

Cite

Share

3

Cite

Share

Priming the 'soil' for breast cancer metastasis: the pre-metastatic niche.

Psaila B, Kaplan RN, Port ER, Lyden D. Psaila B, et al. Breast Dis. 2006-2007;26:65-74. doi: 10.3233/bd-2007-26106. Breast Dis. 2006. PMID: 17473366 Review.

Cite

Share

4

Cite

Share

Bone marrow cells in the 'pre-metastatic niche': within bone and beyond.

Kaplan RN, Psaila B, Lyden D. Kaplan RN, et al. Among authors: psaila b. Cancer Metastasis Rev. 2006 Dec;25(4):521-9. doi: 10.1007/s10555-006-9036-9. Cancer Metastasis Rev. 2006. PMID: 17186383 Review.

Cite

Share

5

Cite

Share

Niche-to-niche migration of bone-marrow-derived cells.

Kaplan RN, Psaila B, Lyden D. Kaplan RN, et al. Among authors: psaila b. Trends Mol Med. 2007 Feb;13(2):72-81. doi: 10.1016/j.molmed.2006.12.003. Epub 2007 Jan 2. Trends Mol Med. 2007. PMID: 17197241 Review.

Cite

Share

6

Cite

Share

Regulation of vasculogenesis by platelet-mediated recruitment of bone marrow-derived cells.

Rafii DC, Psaila B, Butler J, Jin DK, Lyden D. Rafii DC, et al. Among authors: psaila b. Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):217-22. doi: 10.1161/ATVBAHA.107.151159. Epub 2007 Dec 20. Arterioscler Thromb Vasc Biol. 2008. PMID: 18096826 Review.

Cite

Share

7

Cite

Share

Megakaryocytes, malignancy and bone marrow vascular niches.

Psaila B, Lyden D, Roberts I. Psaila B, et al. J Thromb Haemost. 2012 Feb;10(2):177-88. doi: 10.1111/j.1538-7836.2011.04571.x. J Thromb Haemost. 2012. PMID: 22122829 Free PMC article. Review.

Cite

Share

8

Cite

Share

In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation.

Psaila B, Bussel JB, Linden MD, Babula B, Li Y, Barnard MR, Tate C, Mathur K, Frelinger AL, Michelson AD. Psaila B, et al. Blood. 2012 Apr 26;119(17):4066-72. doi: 10.1182/blood-2011-11-393900. Epub 2012 Jan 31. Blood. 2012. PMID: 22294727 Free PMC article.

Cite

Share

9

Cite

Share

Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia.

Psaila B, Bussel JB, Frelinger AL, Babula B, Linden MD, Li Y, Barnard MR, Tate C, Feldman EJ, Michelson AD. Psaila B, et al. J Thromb Haemost. 2011 Nov;9(11):2302-10. doi: 10.1111/j.1538-7836.2011.04506.x. J Thromb Haemost. 2011. PMID: 21920014 Free PMC article.

Cite

Share

10

Cite

Share

Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial.

Bussel JB, Provan D, Shamsi T, Cheng G, Psaila B, Kovaleva L, Salama A, Jenkins JM, Roychowdhury D, Mayer B, Stone N, Arning M. Bussel JB, et al. Among authors: psaila b. Lancet. 2009 Feb 21;373(9664):641-8. doi: 10.1016/S0140-6736(09)60402-5. Lancet. 2009. PMID: 19231632 Clinical Trial.

Cite

Share